Financial Performance Analysis on Market Value In The Pharmaceutical Sector in Indonesia
Keywords:
Current Ratio, Debt to Equity Ratio, Return on AssetAbstract
This study was conducted to determine the effect of company performance measured using financial ratios, namely Return on Assets (ROA), Current Ratio (CR), and Debt to Equity Ratio (DER) to the value of the company as measured by the share price, either simultaneously or partially. The population in this study is the pharmaceutical sector companies listed on the Indonesia Stock Exchange (IDX) in the 2017-2021 period. The sampling technique was done by purposive sampling technique. The number of pharmaceutical sector companies that are used as research samples are 8 companies so that the total research sample is 36 financial statements. Data collection techniques in this study using documentation techniques and data sources used in this study are sources of secondary data obtained by the company's official website for the Indonesia Stock Exchange (IDX). The analysis used is multiple linear regression analysis using the SPSS program (Social Science Statistics Pack) version 25.0. The results of this study indicate that Simultaneously the Return on Assets (ROA), Current Ratio (CR), and Debt to Equity Ratio (DER) variables does not have a significant effect on stock prices. Meanwhile, the return on assets (ROA) has no effect on stock prices. While the Current Ratio (CR) and Debt to Equity Ratio (DER) significant effect on stock prices in Pharmaceutical sector companies listed on the Exchange Indonesian Stock Exchange (IDX) This study was conducted to determine the effect of company performance as measured using financial ratios, namely Return on Assets (ROA), Current Ratio (CR), and Debt to Equity Ratio (DER) to the value of the company as measured by the share price.
